Found 75 matching trials
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
PHASE2A multicenter, prospective, open, randomized cohort, non controlled phase I...
Premenopausal Endocrine Responsive Chemotherapy Trial
PHASE3The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Location
National Institute of Oncology
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
PHASE3This was an open-label, randomized controlled trial that aims to compare th...
Location
Cancer Hospital/ Institute, Fudan University
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
PHASE2The purpose of the investigators study is to compare the efficacy and safet...
Location
Breast cancer institute of Fudan University Cancer Hospital
A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
PHASE2This is a randomized controlled trial of HER-2 positive breast cancer patie...
Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
PHASE2This is an open -label randomized phase II study of dose-dense Fluorouracil...
Location
AKH, Universitätsklinik für Innere Medizin 1
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
PHASE3The purpose of this study is to assess the efficacy of neoadjuvant weekly n...
Location
Royal Adelaide Hospital
The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma
NAHepatocellular carcinoma (HCC) is one of the most common cancers in the wor...
Location
The Second Affiliated Hospital Zhejiang University School of Medicine
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
PHASE2The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
PHASE3This is a multicenter, randomized, open-label phase III study to determine ...
Location
Peking University First Hospital